Data / Form D filings / Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc.: Form D filings
Euthymics Bioscience, Inc., a biotechnology company in Cambridge, MA, filed 6 Form D notices with the SEC between 2010 and 2017. The latest, on June 1, 2017, reports $300,000 sold of a $500,000 offering to 7 investors.
Find out what Euthymics Bioscience, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 43 THORNDIKE STREET, SUITE S1-3, Cambridge, MA, 02141
- Phone
- (617) 758-0300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1066833
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2017 | New notice | $500,000 | $300,000 | $200,000 | 7 | May 23, 2017 | sec.gov |
| Nov 27, 2012 | New notice | $6,000,000 | $3,000,000 | $3,000,000 | 7 | Nov 20, 2012 | sec.gov |
| May 30, 2012 | Amendment | $28,008,945 | $28,008,945 | $0 | 7 | Jul 20, 2010 | sec.gov |
| Mar 16, 2012 | Amendment | $28,008,945 | $24,299,848 | $3,709,097 | 7 | Jul 20, 2010 | sec.gov |
| Mar 17, 2011 | Amendment | $28,414,326 | $22,372,651 | $6,041,675 | 7 | Jul 20, 2010 | sec.gov |
| Jul 29, 2010 | New notice | $24,164,327 | $5,164,326 | $19,000,001 | 6 | Jul 20, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Timothy Barberich | Director | |
| Anthony McKinney | Executive Officer, Director | |
| Campbell Murray | Director | |
| Albert L. Sokol | Executive Officer | |
| Jeffrey Bailey | Director | |
| William Pappafotopoulos | Executive Officer | |
| Paul Weiss | Director | |
| Brigitte Smith | Director | |
| Daniel Omstead | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
Every Form D from the week of May 29, 2017 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Euthymics Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.